We are live on ! Find out more
ZVSA

ZyVersa Therapeutics

Delisted

ZVSA was delisted on the 16th of July, 2025.

7 hedge funds and large institutions have $84.9K invested in ZyVersa Therapeutics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

17% more funds holding

Funds holding: 67 (+1)

1.08% less ownership

Funds ownership: 1.23%0.15% (-1.1%)

53% less capital invested

Capital invested by funds: $181K → $84.9K (-$96.6K)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TSS
1
Two Sigma Securities
New York
$23.4K +$9.45K +1,254 +67%
CSS
2
Cubist Systematic Strategies
Connecticut
$22K +$22.1K +2,937 New
UBS Group
3
UBS Group
Switzerland
$14.9K +$12.5K +1,664 +509%
Jane Street
4
Jane Street
New York
$9.09K +$9.13K +1,212 New
HF
5
HRT Financial
New York
$9K +$9.93K +1,318 New
TRCT
6
Tower Research Capital (TRC)
New York
$6.41K +$3.44K +456 +115%
Wells Fargo
7
Wells Fargo
California
$9
JP Morgan Chase
8
JP Morgan Chase
New York
$1
AFM
9
Anson Funds Management
Texas
-$145K -16,067 Closed
Citadel Advisors
10
Citadel Advisors
Florida
-$13.5K -1,499 Closed